PARP Inhibitor Trial Updates

PARP Inhibitors: 2023 UpdatesПодробнее

Lung cancer trial updates at ASCO 2023Подробнее

Expert report on survival data from pivotal trials with PARP inhibitors for BRCA-mut. Ovarian CancerПодробнее

Advanced Prostate Cancer Clinical Trials Update 2022Подробнее

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel ApproachesПодробнее

PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023Подробнее

Treatment Updates for Advanced Prostate Cancer – 2023 ZERO Prostate Cancer SummitПодробнее

Clinical Trial Updates, and Breast Cancer Outcomes in Black Women: 2023 Best of Breast ConferenceПодробнее

Update on PETRA trial investigating a next-generation PARP1 select inhibitorПодробнее

Updates in PARP inhibition for ovarian cancerПодробнее

Latest updates in low grade serous ovarian cancer treatment and researchПодробнее

PARP Inhibitors: Reducing Ovarian Cancer Recurrence RiskПодробнее

Update on PARP inhibitors in Ovarian and Pancreatic CancerПодробнее

PARP Inhibitors Treatment Update - Summit 2021Подробнее

Updates in Ovarian Cancer TreatmentПодробнее

Updates in Treatment of Ovarian Cancer: PARP InhibitorsПодробнее

Role of PARP Inhibitors in Prostate CancerПодробнее

NERO trial: PARP inhibitors for chemosensitive NSCLCПодробнее

PROFound trial and other recent updates in prostate cancerПодробнее